Why the study?
Repair after ischemic cardiac injury determines progression to heart failure, but better understanding of the intra- and intercellular signaling interplay is needed for therapeutic exploitation.
Single-cell transcriptomics reveals phase-specific changes in cellular heterogeneity during cardiac remodeling and identifies beta-2 microglobulin as a key paracrine signaling molecule and potential therapeutic target for cardiac repair.
The efficiency of the repair process following ischemic cardiac injury is a crucial determinant for the progression into heart failure and is controlled by both intra- and intercellular signaling within the heart. An enhanced understanding of this complex interplay will enable better exploitation of these mechanisms for therapeutic use. We used single-cell transcriptomics to collect gene expression data of all main cardiac cell types at different time-points after ischemic injury. These data unveiled cellular and transcriptional heterogeneity and changes in cellular function during cardiac remodeling. Furthermore, we established potential intercellular communication networks after ischemic injury. Follow up experiments confirmed that cardiomyocytes express and secrete elevated levels of beta-2 microglobulin in response to ischemic damage, which can activate fibroblasts in a paracrine manner. Collectively, our data indicate phase-specific changes in cellular heterogeneity during different stages of cardiac remodeling and allow for the identification of therapeutic targets relevant for cardiac repair.
No takes yet. Share an insight, caveat, or question.
Molenaar et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: